Neuracle reportedly wins first BCI approval in China
March 13, 2026
According to multiple reports, the Chinese medical device regulatory body granted Neuracle the country’s first approval for a brain-computer interface (BCI).
According to multiple reports, the Chinese medical device regulatory body granted Neuracle the country’s first approval for a brain-computer interface (BCI).
Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic reticulum serves as a transport hub and lysosomes help with waste disposal.
Johnson & Johnson (NYSE: JNJ)+ announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
The scanner reconstructs 3D tomographic images by utilising both reflection-mode and transmission-mode ultrasound data.
Karl Storz announced that it received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope.
ANDOVER, Mass. and HAIFA, Israel, March 11, 2026 /PRNewswire/ — MeMed, a leader in advanced host-response diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to MeMed BV Flex™, a test designed to accurately distinguish between bacterial and viral infections based on the body’s immune response.
View offers 2D and 3D visualisation, along with AI-based tools, to assist in clinical decision making.
OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.
MiniMed (Nasdaq:MMED) announced that it received CE mark for the use of its MiniMed 780G with the Instinct sensor made by Abbott.
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.